
- This event has passed.
Investor and Financial Strategy for Life Sciences Startups
June 9, 2021

Session #2: Investor and Financial Strategy for Life Sciences Startups
Get a 360-degree view of the financial aspects of your clinical trial — our panel of experts includes successful entrepreneurs, influential venture investors, and authorities in translational science and clinical development.
Topics
• Risk mitigation/de-risking strategy
• Reimbursement and legal considerations
• Budgeting – Cost expenditures
• Business planning and financial projections
• Best ways to raise capital and prepare for a large investment
• Big company/small company partnerships for funding studies
• Journey of medical device/therapeutic
Agenda
12:00pm – 12:30pm: Opening Remarks
12:05pm – 12:10pm: Panelist Introductions
12:10pm – 1:10pm: Panel Discussion
1:10pm – 1:25pm: Q&A
1:25pm – 1:30pm: Closing Remarks
Panelists
Nancy Briefs – President & CEO, AltrixBio Inc.; Entrepreneur in Residence, UMass M2D2
Daniel Gottlieb – Associate Director, Broadview Ventures
Bill Yelle – Entrepreneur in Residence, Mass General Brigham Ventures
Vinit Nijhawan – Managing Director, MassVentures
Anna O’Rourke – Senior Advisor and SME of Clinical Development, Biomedical Advanced Research and Development Authority
Moderator: Nathaniel Hafer – Director of UMass Center for Clinical and Translational Science, UMass Medical